Showing 1 to 10 of 10 entries Per page:
Compound ID Target/Cell Structure Activity Assay Description Source
NAs.000017 8 ribose-match Adenosine A1 receptor NAs.000017 Other = 14.0 % Displacement of [3H]R-PIA from human recombinant adenosine A1 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting CHEMBL2062514
NAs.000017 8 ribose-match Adenosine A2a receptor NAs.000017 Other = 30.0 % Displacement of [3H]CGS21680 from human recombinant adenosine A2A receptor expressed in HEK293 cells at 10 uM after 60 mins by liquid scintillation counting CHEMBL2062514
NAs.000017 8 ribose-match Adenosine A3 receptor NAs.000017 Ki = 1.22 nM Displacement of [3H]I-AB-MECA from human recombinant adenosine A3 receptor expressed in CHO cells after 60 mins by gamma counting CHEMBL2062514
NAs.000017 8 ribose-match Adenosine A3 receptor NAs.000017 Other = 97.4 % Agonist activity at human recombinant adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production at 10 uM incubated for 30 mins prior to forskolin-stimulation measured after 15 mins by enzyme immunoassay relative to NECA CHEMBL2062514
NAs.000017 8 ribose-match Adenosine A1 receptor NAs.000017 Other = 13.0 % Displacement of [3H]R-PIA from human recombinant A1 adenosine receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting CHEMBL3407461
NAs.000017 8 ribose-match Adenosine A2a receptor NAs.000017 Other = 30.0 % Displacement of [3H]CGS21680 from human recombinant A2A adenosine receptor expressed in HEK293 cells at 10 uM after 60 mins by liquid scintillation counting CHEMBL3407461
NAs.000017 8 ribose-match Adenosine A3 receptor NAs.000017 Ki = 1.22 nM Displacement of [125I]I-AB-MECA from human recombinant A3 adenosine receptor expressed in CHO cells after 60 mins by liquid scintillation counting CHEMBL3407461
NAs.000017 8 ribose-match Mus musculus NAs.000017 Other = 0.5 hr Antinociceptive activity in chronic constriction injury neutropathic pain CD-1 mouse model assessed as time for peak protection at 3 umol/kg, po CHEMBL3407461
NAs.000017 8 ribose-match Mus musculus NAs.000017 Other = 40.4 % Antinociceptive activity in chronic constriction injury neutropathic pain CD-1 mouse model assessed as maximum protection on ipsilateral hind paw at 3 umol/kg, po after 30 mins to 5 hrs post dose relative to control CHEMBL3407461
NAs.000017 8 ribose-match Mus musculus NAs.000017 Other = 4.6 % Antinociceptive activity in chronic constriction injury neutropathic pain CD-1 mouse model at 3 umol/kg, po after 3 hrs post dose relative to control CHEMBL3407461